Atrás
Rango del Día
$28.20
$30.26
Rango de 52 Semanas
$13.70
$36.03
Volumen
117,346
Promedio 50D / 200D
$24.16
/
$20.94
Cierre Anterior
$29.44
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -7.6 | 0.3 |
| P/B | 2.3 | 2.9 |
| ROE % | -37.8 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$60.00
+99.5%
EPS Futuro
-$4.85
Ingresos Est.
0
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
-$4.19
-$4.19 – -$4.19
|
140 M | 6 |
| FY2029 |
-$6.29
-$6.29 – -$6.29
|
42 M | 6 |
| FY2028 |
-$5.61
-$9.35 – -$2.25
|
0 | 8 |
Puntos Clave
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -60.29M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-37.82%
ROIC-24.95%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.01
Current Ratio26.63
Interest Coverage-1333.90
Valoración
P/E Ratio
-7.61
P/B Ratio2.25
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -74.15M |
| ROE | -37.82% | ROA | -28.41% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -60.29M |
| ROIC | -24.95% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 26.63 |
| Interest Coverage | -1333.90 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.61 | P/B Ratio | 2.25 |
| P/S Ratio | N/A | PEG Ratio | -1.69 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 564.61M | Enterprise Value | 312.09M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -74.15M | -57.98M | -42.82M | -32.18M | -8.93M |
| EPS (Diluted) | -4.05 | -3.93 | -11.53 | -29.05 | -33.36 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -84.04M | -58.02M | -44.65M | -32.83M | -15.61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 261.04M | 152.91M | 39.40M | 47.21M | 32.88M |
| Total Liabilities | 9.71M | 12.13M | 124.04M | 92.86M | 47.84M |
| Shareholders' Equity | 251.33M | 140.78M | -84.64M | -45.65M | -14.96M |
| Total Debt | 1.28M | 3.30M | 4.34M | 5.79M | 1.06M |
| Cash & Equivalents | 253.80M | 141.24M | 28.77M | 35.97M | 28.06M |
| Current Assets | 257.36M | 146.86M | 30.88M | 37.04M | 28.62M |
| Current Liabilities | 9.67M | 11.61M | 40.89M | 7.84M | 4.12M |